Raymond James Financial’s Mesa Laboratories MLAB Stock Holding History

Raymond James Financial’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.7M	Buy	122,911 +22,514	+22%	+$1.94M	﹤0.01%	1964
2025 Q4	$7.89M	Buy	100,397 +52,995	+112%	+$4.03M	﹤0.01%	2153
2025 Q3	$3.18M	Sell	47,402 -138,153	-74%	-$9.94M	﹤0.01%	2809
2025 Q2	$17.5M	Sell	185,555 -78,458	-30%	-$8.61M	0.01%	1474
2025 Q1	$31.3M	Buy	264,013 +16,218	+7%	+$2.21M	0.01%	995
2024 Q4	$32.7M	Buy	+247,795	New	+$30.4M	0.01%	976

Other funds holding MLAB

LPP

Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Raymond James Financial's MLAB Position: Q1 2026 in Review

Raymond James Financial increased its Mesa Laboratories (MLAB) stake by 22% in Q1 2026, buying an estimated $1.94M and bringing the position to 122,911 shares worth $10.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1964.

Raymond James Financial first reported a position in MLAB in Q4 2024 and has held it in 6 quarters since. The position peaked at $32.7M in Q4 2024. 161 funds tracked by Wall St. Rank hold MLAB as of Q1 2026.

Raymond James Financial held 122,911 shares of Mesa Laboratories worth $10.7M as of Q1 2026.
Raymond James Financial bought 22,514 Mesa Laboratories shares in Q1 2026, an estimated $1.94M.
Mesa Laboratories made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #1964 holding.
Raymond James Financial first reported a position in Mesa Laboratories in Q4 2024 and has held it in 6 quarters since.
Raymond James Financial's Mesa Laboratories position peaked at $32.7M in Q4 2024.
161 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.